Trump's 100-day Game: Glory or Predicament?
Recently, the White House announced that Trump will hold a rally in Michigan on April 29th to celebrate his 100th day in office.
更多Recently, the White House announced that Trump will hold a rally in Michigan on April 29th to celebrate his 100th day in office.
更多On April 26th local time, a violent explosion occurred at Shahid Rajai Port in southern Iran, causing significant casualties and property damage. As of now, the explosion has resulted in at least 14 deaths and over 750 injuries.
更多In April, one of the focal points in international financial markets has been the structural adjustment in US dollar asset allocation.
更多The US government is currently facing strong backlash from both at home and abroad for implementing radical tariff policies.
更多US President Trump claimed that a "detailed peace plan" related to the Russia-Ukraine conflict would be announced within the next three days. As soon as this news came out, it immediately drew widespread attention from the international community and different responses from all parties.
更多In April 2025, Harvard University sued the Trump administration, and soon after, over a hundred universities jointly issued a statement opposing "political interference".
更多According to the latest survey, most Americans now show little or no confidence in the way President Donald Trump handles the economy, which has long been the source of his political strength.
更多Recently, US President Trump unexpectedly participated in the trade negotiations with Japanese officials in person and said that the negotiations had made "significant progress".
更多According to CNBC's latest national economic survey, Trump's approval rating on economic issues has hit a new low in his presidential career due to widespread dissatisfaction with his handling of tariffs, inflation and government spending.
更多According to people familiar with the matter, the Trump administration is planning a new policy that could trigger a strong backlash from the pharmaceutical industry: aligning US drug prices with the generally lower levels of other developed countries.
更多